Crohn's-like ileo-colitis in patients affected by glycogen storage disease Ib: Two years' follow-up of patients with a wide spectrum of gastrointestinal signs

Acta Paediatrica, International Journal of Paediatrics

Volumn 92, Issue 12, 2003, Pages 1415-1421

  Melis, D ^a   Parenti, G ^a   Della Casa, R ^a   Sibilio, M ^a   Canani, R Berni ^a   Terrin, G ^a   Cucchiara, S ^a,b   Andria, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Crohn's disease; G CSF; Glycogen storage disease Ib; Neutropenia

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BARIUM; GRANULOCYTE COLONY STIMULATING FACTOR; STEROID; TECHNETIUM 99M;

ADOLESCENT; ADULT; ARTICLE; BARIUM MEAL; CHILD; CLINICAL ARTICLE; COLON CROHN DISEASE; COLONOSCOPY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; ECHOGRAPHY; ENTERITIS; EVALUATION; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLYCOGEN STORAGE DISEASE; HISTOLOGY; HUMAN; ILEITIS; ILEUM DISEASE; LEUKOCYTE; MALE; NUTRITION; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COLONOSCOPY; CROHN DISEASE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GLYCOGEN STORAGE DISEASE TYPE I; HUMANS; MALE;

EID: 1642575407     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035250310007033     Document Type: Article

References (32)

1. Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY. Mutations in the glucose-phosphatase gene that cause glycogen storage disease type Ia. Science 1993; 262: 580-3
2. Galli L, Orrico A, Marcolongo P, Fulceri R, Burchell A, Melis D, et al. Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage disease type Ib and Ic. FEBS Lett 1999; 459: 255-8
3. Beaudet AL, Anderson DC, Michels VV, Arion WJ, Lange AJ. Neutropenia and impaired neutrophil migration in type Ib glycogen storage disease. J Pediatr 1980; 97: 906-10
4. Gitzelmann R, Boshard NU. Defective neutrophil and monocyte function in glycogen storage disease type Ib: a literature review. Eur J Pediatr 1993; 152: S33-8
5. Rake JP, ten Berge AM, Visser G, Verlind E, Niezen-Koning KE, Buys CH, et al. Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart. Eur J Pediatr 2000; 159: 322-30
6. Fernandes J, Jansen H, Jansen TC. Nocturnal gastric drip feeding in glucose-6-phosphatase deficient children. Pediatr Res 1984; 18: 879-81
7. Smit GP, Berger R, Potasnick R, Moses SW, Fernandes J. The dietary treatment of children with type I glycogen storage disease with slow release carbohydrate. Pediatr Res 1979; 13: 225-9
8. Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, et al. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and/or neutrophil dysfunction secondary to glycogen storage disease type Ib. Blood 2001; 97: 376-82
9. Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr 2000; 137: 187-91
10. Visser G, Rake JP, Kokke FTM, Nikkels PGJ, Sauer PJJ, Smit GPA. Intestinal function in glycogen storage disease type I. J Inherit Metab Dis 2002; 25: 261-7
11. Dieckgraefe BK, Korzenik JR, Husain A, Dieruf L. Association of glycogen storage disease Ib and Crohn disease: results of a North American survey. Eur J Pediatr 2002; 161: S88-S92
12. Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci 2000; 45: 1121-9
13. Hyams JS. Crohn's disease. In: Willy R, Hyams JS, editors. Pediatric gastrointestinal disease. Philadelphia: WB Saunders; 1993: 742-64
14. Kirschner BS. Inflammatory bowel disease in children. Pediatr Clin North Am 1988; 35: 189-208
15. Williams CB, Laage NJ, Campbell CA, Douglas JR, Walker-Smith JA, Booth IW, et al. Total colonoscopy in children. Arch Dis Child 1982; 57: 49-53
16. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of a Pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991; 12: 439-47
17. Parente F, Maconi G, Bollani S, Anderloni A, Sampietro G, Cristaldi M, et al. Bowel ultrasound in assessment of Crohn's disease and detection of related small bowel strictures: a prospective comparative study versus x-ray and intraoperative findings. Gut 2002; 50: 490-5
18. Brown AL, Skehan SJ, Greaney T, Rawlinson J, Somers S, Stevenson GW. Value of double-contrast barium enema performed immediately after incomplete colonoscopy. AJR Am J Roentgenol 2001; 176: 943-5
19. Cucchiara S, Celentano L, de Magistris TM, Montisci A, Iula VD, Fecarotta S. Colonoscopy and technetium-99 m white cell scan in children with suspected inflammatory bowel disease. J Pediatr 1999; 135: 727-32
20. Saverymuttu SH, Camilleri M, Rees H, Lavander JP, Hodgson HJF, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. Gastroenterology 1986; 90: 1121-8
21. Vermiere S, Joossens S, Peeters M, Monsuur F, Marien G, Bossuyt X, et al. Comparative study of ASCA assays in inflammatory bowel disease. Gastroenterology 2001; 120: 827-33
22. Ruemmele FM, Targan SR, Levy G, Dubinsky M, Braun J, Seidman EG. Diagnostic accuracy of serological assay in pediatric inflammatory bowel disease. Gastroenterology 1998; 115: 822-9
23. Griffiths A, Koletzko S, Sylvester F, Marcon M, Sherman P. Slow-release 5-aminosalicylic acid therapy in children with small intestinal Crohn's disease. J Pediatr Gastroenterol Nutr 1993; 17: 186-92
24. Cangemi GR. The role of antibiotics in Crohn's disease. Dig Dis 1999; 17: 1-5
25. Arnold GL, Beaves MR, Pryjdun VO, Mook WJ, Arnold GL, Beaves MR, et al. Preliminary study of ciprofloxacin in active Crohn's disease. Inflamm Bowel Dis 2002; 8: 10-5
26. Gorard DA, Hunt JB, Payne-James JJ, Palmer KR, Rees RG, Clark ML, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1993; 34: 1198-202
27. Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 1994; 19: 175-80
28. Goldstein F. Look out for toxic effects of mesalamines! J Clin Gastroenterol 2001; 32: 98
29. Birketvedt GS, Berg KJ, Fausa O, Florholmen J. Glomerular and tubular renal functions after long-term medication of sulphasulazine, olsalazine, and mesalazine in patients with ulcerative colitis. Inflamm Bowel Dis 2000; 6: 275-9
30. Colombel JF, Brabant G, Gubler MC, Locquet A, Comes MC, Dehennault M, et al. Renal insufficiency in infants: side-effect of prenatal exposure to mesalazine? Lancet 1994; 344: 620-1
31. Reitsma-Bierens WC. Renal complications in glycogen storage disease type I. Eur J Pediatr 1993; 152: S60-2
32. Chen YT. Type I glycogen storage disease: kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 1991; 5: 71-6